Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, ...

Fosun Pharmaceutical is a spinoff from Fosun International, which is chaired by China billionaire chairman Guo Guangchang; ...

With $6 billion left in firepower, Pfizer is planning transactions in the hundreds of millions to the low-billions range, ...

Fresh from a blockbuster rights deal with drugs giant Pfizer earlier this year, 3SBio has announced a subsidiary spin-off and ...

Pfizer’s recent bidding war for an obesity biotech clearly hasn’t satiated the pharma’s appetite for new GLP-1 therapies—at least going by ...